Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy.
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
[Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Reduced Sterol Regulatory Element-Binding Protein (SREBP) Processing Through Site-1 Protease (S1P) inhibition Alters Oligodendrocyte Differentiation in vitro.
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta.
Pemetrexed-Induced Nephrogenic Diabetes Insipidus.
Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.
Accelerated longitudinal gray/white matter contrast decline in aging in lightly myelinated cortical regions.
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.
Perceived Exertion Is Lower When Using a Functional Electrical Stimulation Neuroprosthesis Compared With an Ankle-Foot Orthosis in Persons With Multiple Sclerosis: A Preliminary Study.
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.
Chemical exchange saturation transfer of the cervical spinal cord at 7 T.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Gene expression profiling in multiple sclerosis brain.
Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.
The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.
Pages
« first
‹ previous
…
687
688
689
690
691
692
693
694
695
…
next ›
last »